Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer

Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer

Oncolytic viruses (OVs), without harming normal tissues, selectively infect and replicate within tumor cells, to release immune molecules and tumor antigens, achieving immune-mediated destruction of tumors and making them one of the most promising immunotherapies for cancer. Many clinical studies ha...

Full description

Bibliographic Details
Main Authors: Zhan Wang, Peng Sun, Zhiyong Li, Shaowen Xiao
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cancers
Subjects:
head and neck cancer
oncolytic viruses
clinical trials
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/15/21/5291

Similar Items

Similar Items